ALK-Abelló (Denmark)

ALK-Abelló A/S, also commonly known as ALK, is a Denmark-based pharmaceutical company which specializes in the development and manufacturing of allergy immunotherapy products for the prevention and treatment of allergy. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for ALK-Abelló (Denmark), Denmark, covering academic research published from 2000 to 2024. Read More.

Open Access Percentage

44%

Total
Publications

849

Total Open
Publications

374

Total
Citations

32K

Open Access
Percentage

44%

Total
Publications

849

Total Open
Publications

374

Total
Citations

32K

Wikipedia

Website

download

Breakdown

Publisher Open

27%

Both

13%

Other Platform Open

Closed

56%

Percentage of Open Access over time

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

Open

Closed

Publisher Open

OA Journal 27%

Hybrid 18%

No Guarantees 55%

188

Other Platform Open

Domain 57%

Institution 35%

Other Internet 23%

Preprint 2%

Public 1%

Other Platform Locations

Name	Platform Type	Publications
PubMed Central	Domain	83
DOI	Other Internet	27
Unknown Repository	Other Internet	8
King's College London	Institution	7
Europe PMC	Domain	6
helmholtz-muenchen.de OAI-PMH Repository	Institution	5
University of Ferrara	Institution	3
Technical University of Munich	Institution	3
Servicio Gallego de Salud	Institution	3
Imperial College London	Institution	3

1 / 4

Data updated 18 August 2025